Background
Methods
Design and setting
Data sources
Data and measurement
Outcomes
Statistical analyses
Ethics
Results
Participant characteristics
Variables | N (%) |
---|---|
Women
| 2171 (100) |
Age*
| |
Young | 717 (33) |
Middle | 716 (33) |
Older | 738 (34) |
Income**
| |
Low | 715 (33) |
Middle | 714 (33) |
High | 715 (34) |
Ethnicity
| |
Caucasian (Danish/other) | 1981 (92.3) |
Asian/middle eastern | 128 (5.9) |
African | 61 (2.8) |
Mean
|
SD
|
Birth of diagnosis | 0.8 |
1.6 | |
Age | 5.0 |
30.9 |
Participation in follow-up screening
Follow-up screening | Diabetes women (N = 124) | Treatment women (N = 229) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Control + N (%) | Control – N (%) | Missing N (%)* | p | Control + N | Control – N | p | Control + N | Control – N | p | |
General practitioner (N = 2171)
| ||||||||||
Control 1: Within 3 months after birth | 1744 (80.5) | 423 (19.5) | 41 (0.2) | <0.001 | 112 | 12 | 0.0045 | 205 | 24 | 0.0002 |
Control 2: 3 months to 2 years | 852 (47.3) | 950 (52.7) | 369 (17.0) | 0.0210 | 108 | 16 | <0.0001 | 188 | 37 | <0.0001 |
Control 3: 2 years to 4 years | 526 (29.1) | 1281 (70.9) | 364 (16.8) | <0.001 | 94 | 27 | <0.0001 | 152 | 62 | <0.0001 |
Control 4: 4 years to 6 years | 333 (17.7) | 1551 (82.3) | 287 (12.8) | <0.001 | 75 | 37 | <0.0001 | 116 | 89 | <0.0001 |
Biochemical unit** (N = 1218)
| ||||||||||
Control 1: Within 6 months after birth | 111 (10.2) | 979 (89.8) | 128 (10.5) | <0.001 | 113 | 10 | 0.4932 | 181 | 40 | <0.0001 |
Control 2: 6 moths to 2.4 years | 69 (6.4) | 1013 (93.6) | 136 (11.2) | <0.001 | 113 | 10 | 0.8829 | 184 | 36 | <0.0001 |
Control 3: 2.4 years to 4.5 years | 29 (2.5) | 1116 (97.5) | 73 (6.0) | <0.001 | 113 | 9 | 0.3085 | 192 | 28 | <0.0001 |
Control 4: 4.5 years to 8.2 years | 6 (0.5) | 1190 (99.5) | 22 (1.8) | <0.001 | 115 | 5 | 0.7766 | 198 | 22 | <0.0001 |
Crude OR (95% CI) | Adjusted* OR (95% CI) | |
---|---|---|
General practitioner
| ||
Control 1: Within 3 months after birth | 2.4(1.3-4.3) | 2.4 (1.3-4.4) |
Control 2: 3 months to 2 years | 8.6 (5.1-14.7) | 8.3 (4.8-14.1) |
Control 3: 2 years to 4 years | 10.1 (6.5-15.7) | 9.8 (6.2-15.3) |
Control 4: 4 years to 6 years | 11.9 (7.9-18.0) | 11.8 (7.7-18.0) |
Biochemical unit**
| ||
Control 1: Within 6 months after birth | 1.4 (0.4-4.9) | 0.9 (0.2-4.1) |
Control 2: 6 months to 2.4 years | 2.4 (0.7-8.2) | 1.5 (0.3-6.9) |
Control 3: 2.4 years to 4.5 years | 4.3 (0.9-19.2) | 1.7 (0.2-14) |
Control 4: 4.5 years to 8.2 years*** | - | - |
Crude OR (95% CI) | Adjusted* OR (95% CI) | |
---|---|---|
General practitioner
| ||
Control 1: Within 3 months after birth | 2.2 (1.5-3.5) | 2.3 (1.5-3.5) |
Control 2: 3 months to 2 years | 7.4 (5.1-10.6) | 7.1 (4.9-10.3) |
Control 3: 2 years to 4 years | 8.1 (5.9-11.2) | 8.1 (5.9-11.3) |
Control 4: 4 years to 6 years | 8.8 (6.5-12.1) | 8.9 (6.5-12.2) |
Biochemical unit**
| ||
Control 1: Within 6 months after birth | 3.1 (1.7-5.5) | 2.9 (1.6-5.3) |
Control 2: 6 months to 2.4 years | 3.8 (2.0-7.3) | 3.5 (1.8-6.9) |
Control 3: 2.4 years to 4.5 years | 3.3 (1.2-8.9) | 2.5 (0.8-7.4) |
Control 4: 4.5 years to 8.2 years | 7.9 (1.4-43.8) | 8.7 (1.5-49.4) |
Diabetes | Treatment | |||||
---|---|---|---|---|---|---|
N | Crude | Adjusted | N | Crude | Adjusted | |
HR (95% CI) | HR (95% CI)* | HR (95% CI) | HR (95% CI) | |||
Min. 1 control at general practitioner (n = 2123) | 124/2123 | 2.6 (1.15-5.9) | 2.7 (1.1-5.9) | 229/2089 | 2.1 (1.2-3.5) | 2.1 (1.2-3.5) |
Min. 1 control at a biochemical unit** | 22/1211 | 1.1 (0.3-3.9) | 0.8 (0.1-3.3) | 77/1202 | 2.2 (1.3-3.8) | 2.1 (1.2-3.6) |